CVM CEL-SCI Corp.

-

CEL-SCI Reported Earnings

Friday, August 14, 2026 · 12:00 AM ET

CEL-SCI (CVM) reported a loss of $0.47 per share on revenue of $0.00 million for the . .

CEL-SCI Corp is a biotechnology company. It is engaged in the research & development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body' natural defense system.

Earnings Whisper Grade
Power Rating
Reported Earnings
($0.47)
Earnings Whisper®
Consensus Estimate
Earnings Surprise
Earnings Growth65.4 %
Reported Revenue
Revenue Estimate
Revenue Surprise
Revenue Growth